[Treatment of hyperlipoproteinemias (author's transl)].
D000293:Adolescent; D000328:Adult; D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D002648:Child; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D003918:Dextrothyroxine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006937:Hypercholesterolemia / Q000188:drug therapy; D006949:Hyperlipidemias / Q000188:drug therapy*; D007475:Ion Exchange Resins / Q000627:therapeutic use*; D008074:Lipoproteins / Q000097:blood*; D008077:Lipoproteins, LDL / Q000097:blood; D008079:Lipoproteins, VLDL / Q000097:blood; D008297:Male; D008687:Metformin / Q000627:therapeutic use; D008875:Middle Aged; D009539:Nicotinic Acids / Q000627:therapeutic use*; D010629:Phenformin / Q000627:therapeutic use
D000924:Anticholesteremic Agents; D007475:Ion Exchange Resins; D008074:Lipoproteins; D008077:Lipoproteins, LDL; D008079:Lipoproteins, VLDL; D009539:Nicotinic Acids; D002792:Cholestyramine Resin; D003918:Dextrothyroxine; D008687:Metformin; D010629:Phenformin; D002994:Clofibrate
Terapia delle iperlipoproteinemie